Skip to main content
Home
Donate Now
Donate Now

Main navigation

  • Our Scientists
  • Biomedical Research
    • Overview
    • Programs
    • Centers
    • Translational Research
    • Shared Resources
    • Partnering
  • Education
    • Overview
    • Postdoctoral Training
    • Graduate School
    • International Services
    • NIH T32 Fellowships
    • Contact
  • News & Calendar
    • News
    • Calendar
    • Magazine
    • Media Resources
    • Discoveries Newsletter
    • COVID-19
  • Support Us
    • Donate Now
    • Leave a Legacy
    • Monthly Giving
    • Tributes
    • Contact
  • About
    • Overview
    • Leadership
    • Trustees
    • History
    • Careers
    • DEI
    • Contact

Main navigation

  • Our Scientists
  • Biomedical Research
    • Overview
    • Programs
    • Centers
    • Translational Research
    • Shared Resources
    • Partnering
  • Education
    • Overview
    • Postdoctoral Training
    • Graduate School
    • International Services
    • NIH T32 Fellowships
    • Contact
  • News & Calendar
    • News
    • Calendar
    • Magazine
    • Media Resources
    • Discoveries Newsletter
    • COVID-19
  • Support Us
    • Donate Now
    • Leave a Legacy
    • Monthly Giving
    • Tributes
    • Contact
  • About
    • Overview
    • Leadership
    • Trustees
    • History
    • Careers
    • DEI
    • Contact

News

Main navigation - LV 2

  • News
  • Calendar
  • Magazine
  • Media Resources
  • Discoveries Newsletter
  • COVID-19

News

  • All
  • Press Releases
  • In The News
  • Blog
  • Paper of the Week
iScience logo

Ligands with different dimeric configurations potently activate the EphA2 receptor and reveal its potential for biased signaling

February 4, 2022
Journal of Biological Chemistry (JBC) logo

Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells

January 11, 2022
The FASEB Journal logo

Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1P1-selective modulation

January 5, 2022
nature communications logo

A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing

November 11, 2021
Journal of Medicinal Chemistry logo

Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia

November 22, 2021

Pagination

  • « First
  • ‹ ‹
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • › ›
  • » Last
SBPdiscovery

Sanford Burnham Prebys Newsletter

Subscribe to our monthly email newsletter Discoveries.

 

Connect with us

Follow us on social media for the latest from Sanford Burnham Prebys.

Charity Navigator Four-Star Rating

Main navigation

  • Our Scientists
  • Biomedical Research
    • Overview
    • Programs
    • Centers
    • Translational Research
    • Shared Resources
    • Partnering
  • Education
    • Overview
    • Postdoctoral Training
    • Graduate School
    • International Services
    • NIH T32 Fellowships
    • Contact
  • News & Calendar
    • News
    • Calendar
    • Magazine
    • Media Resources
    • Discoveries Newsletter
    • COVID-19
  • Support Us
    • Donate Now
    • Leave a Legacy
    • Monthly Giving
    • Tributes
    • Contact
  • About
    • Overview
    • Leadership
    • Trustees
    • History
    • Careers
    • DEI
    • Contact

© 2023 Sanford Burnham Prebys. All Rights Reserved.

Footer Bottom

  • Privacy
  • Financial Conflict of Interest Policy
  • State Nonprofit Disclosures